Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
May 7th, 2018 |
The Health of Sexual and Gender Minority (SGM) Populations (R21 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2018 |
The Health of Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2018 |
Research on Informal and Formal Caregiving for Alzheimer's Disease (R01 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2021 |
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) |
National Institutes of Health |
January 7th, 2021 |
Academic Research Enhancement Award (R15 Clinical Trial Required) |
National Institutes of Health |
May 7th, 2018 |
Functional Wellness in HIV: Maximizing the Treatment Cascade (R21 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2018 |
Prevention Research in Mid-Life Adults (R21 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2018 |
Functional Wellness in HIV: Maximizing the Treatment Cascade (R01 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2019 |
Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2020 |
Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R21 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2020 |
Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R01 Clinical Trial Optional) |
National Institutes of Health |
January 8th, 2018 |
Emergency Medical Services for Children State Partnership Program |
Health Resources and Services Administration |
January 7th, 2021 |
NIH Research Project Grant (Parent R01 Clinical Trial Required) |
National Institutes of Health |
May 7th, 2018 |
Prevention Research in Mid-Life Adults (R01 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2020 |
Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R03 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R03 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2019 |
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R21 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2019 |
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) |
National Institutes of Health |
|
January 7th, 2020 |
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional) |
National Institutes of Health |
November 17th, 2017 |
Population-based HIV Impact Assessments in Resource-Constrained Settings under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
January 17th, 2018 |
NCI Research Specialist (Core-based Scientist) Award (R50) |
National Institutes of Health |
January 17th, 2018 |
NCI Research Specialist (Laboratory-based Scientist) Award (R50) |
National Institutes of Health |
February 29th, 2020 |
NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) |
National Institutes of Health |
May 7th, 2020 |
Improving Outcomes for Disorders of Human Communication (R21 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
Neuroscience Research on Drug Abuse (R01 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2019 |
Characterization of the Adolescent Reproductive Transition (R03 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2019 |
Characterization of the Adolescent Reproductive Transition (R21 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R01 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2019 |
Characterization of the Adolescent Reproductive Transition (R01 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2018 |
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2018 |
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) |
National Institutes of Health |
January 24th, 2018 |
Emerging Infectious Sentinel Networks (EISN) Research |
Centers for Disease Control and Prevention ERA |
January 31st, 2018 |
Minority HIV/AIDS Research Initiative (MARI) to Build HIV Prevention, Treatment and Research Capacity in Disproportionately Affected Black and Hispanic Communities and Among Historically Underrepresented Researchers |
Centers for Disease Control and Prevention ERA |
June 28th, 2019 |
Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R33 Clinical Trial Required) |
National Institutes of Health |
May 7th, 2019 |
Prescription Drug Abuse (R01 Clinical Trial Optional) |
National Institutes of Health |